A Fuzzy Controller for Blood Glucose-Insulin System
|
|
|
- Brittany Armstrong
- 9 years ago
- Views:
Transcription
1 Journal of Signal and Information Processing, 213, 4, Published Online May 213 ( 111 Ahmed Y. Ben Sasi 1, Mahmud A. Elmalki 2 1 The College of Industrial Technology, Misurata, Libya; 2 Misurata University, Misurata, Libya. [email protected], [email protected] Received December 28 th, 212; revised January 25 th, 213; accepted February 4 th, 213 Copyright 213 Ahmed Y. Ben Sasi, Mahmud A. Elmalki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Diabetes therapy is normally based on discrete insulin infusion that uses long-time interval measurements. Nevertheless, in this paper, a continuous drug infusion closed-loop control system was proposed to avoid the traditional discrete approaches by automating diabetes therapy. Based on a continuous insulin injection model, two controllers were designed to deal with this plant. The controllers designed in this paper are: proportional integral derivative (PID), and fuzzy logic controllers (FLC). Simulation results have illustrated that the fuzzy logic controller outperformed the PID controller. These results were based on serious disturbances to glucose, such as exercise, delay or noise in glucose sensor and nutrition mixed meal absorption at meal time. Keywords: Diabetes; Blood Glucose; Closed-Loop; Continuous Insulin Infusion; PID Controller; Fuzzy Logic Controller 1. Introduction Many researchers have attempted to find methods for diagnosing and treating diabetes disease. One of the approaches is to design an automated closed-loop insulin delivery system. A fully automated closed-loop insulin delivery system (also known as an artificial pancreas) could potentially be the ultimate answer for blood glucose (BG) control in diabetic patients. This system can mimic the activity of a normal pancreas and is capable of maintaining physiological BG levels for insulin-dependent diabetic patients. Such an artificial pancreas system can theoretically produce tight glucose control without finger-stick BG measurements, subcutaneous insulin injections, or hypoglycemic/hyperglycemic events, thereby, dramatically improves the quality of life for an insulin-dependent diabetic patient. The artificial pancreas is a system of integrated devices containing only synthetic materials, which substitutes for a pancreas by sensing plasma glucose concentration, calculating the amount of insulin needed, and then delivering the correct amount of insulin. Typically, such a device is comprised of a glucose monitoring sensor, an insulin pump, and a control algorithm to regulate the pump to deliver the insulin in order to maintain normoglycemia in presence of sensor measurements. Figure 1 shows a basic block diagram of this type of Figure 1. Block diagram of closed-loop insulin delivery system. Copyright 213 SciRes.
2 112 closed-loop control for the regulation of glucose levels. In this figure, a controller receives the difference between the glucose set point (desired BG) and the glucose reading, and uses this information to continuously adjust the rate of insulin delivery. The insulin infusion and glucose measurements are either invasive or non-invasive, however, usually achieve using the subcutaneous route [1,2]. This closed-loop control is very similar to the function that is performed by a healthy human pancreas; in other words, the research s aim is to design a device that essentially functions as an artificial pancreas. This paper emphasises the need of a good quality controller when it comes to critical diabetes situations. 2. The Mathematical Model of Diabetes In order to have a reliable automatic insulin delivery system operating under various physiological conditions, a model must be synthesized that has glucose-predicting ability and includes all the major energy-providing substrates at rest, as well as during physical activity. The mathematical models of metabolism proposed, in this paper, are glucose-based and have the contribution of free fatty acid (FFA) metabolism, which is an important source of energy for the body. Also, significant interactions exist among FFA, glucose, and insulin. It is important to consider these metabolic interactions in order to characterize the endogenous energy production of a healthy or a diabetic patient. Furthermore, physiological exercises are taken into account to induce the fundamental metabolic changes in the body. Figure 2 shows the simulation of a composite model which is capable of predicting FFA-glucose-insulin dynamics during rest and exercise [3]. A mixed meal model was employed to capture the absorption of carbohydrates (CHO), proteins, and FFA from Figure 2. Composite model simulation of diabetic patient. Copyright 213 SciRes.
3 113 the gut into the circulatory system [4]. An exercise model was used to incorporate the effects of exercise on glucose and insulin dynamics to capture the changes in glucose and insulin dynamics during and after mild-to-moderate exercise. The mixed meal, and exercise models served as a disturbance to the proposed model. The overall diabetic plant comprises of 34 differential algebraic equations, which describe 2 states. The diabetic plant includes the composite model, and its disturbances (mixed meal, and exercise models). The model successfully captured the FFA-glucose interactions at the systemic level, and also effectively predicted mild-to-moderate exercise effects on glucose and FFA dynamics. Accordingly, this composite model was selected in this work to provide a platform for the development of closed-loop controllers to maintain glucose homeostasis of a diabetic patient. 3. Controllers Design and Simulation Various types of control algorithms for blood glucose control have been reported in the literature. Some of these algorithms include: PID control [5,6], and fuzzy logic control [1,2]. However, our studies have focused on using the successfully captured FFA-glucose-insulin dynamics composite model presented in section two, which has never been used before for control purposes, to developing two control algorithms: the PID and the fuzzy logic controllers using Matlab/Simulink. The target blood glucose range that the controllers were supposed to attain and maintain is similar to healthy blood-glucose levels. The proposed blood-glucose range is between 7 mg/dl and 12 mg/dl before meals and less than 18 mg/dl after meals [5], and the maximum insulin infusion rate is constrained to 1 mu/min The PID Controller The most traditional of all controllers is probably the proportional integral derivative (PID) controller. A PID controller uses a proportional term, an integral term, and a derivative term, each with a coefficient that provides a weight for that term. In many processes, especially industrial, PID controllers are used to keep some kind of a steady state. The controller takes a measurement from a plant process (diabetic mathematical model) and compares it with a set-point (reference) value of BG concentration. The difference (or error signal) is then used to adjust the input to the plant in order to bring the measured value back to its desired set-point. PID controller can adjust process outputs based on the history and rate of change of the error signal. The schematic diagram of the PID controller used with the composite model is shown in Figure The Fuzzy Logic Controller (FLC) In the control theory field, fuzzy logic has emerged as a powerful tool to incorporate expert knowledge about systems into the controllers design. In particular, the ability of synthesizing expert knowledge in the fuzzy logic framework has raised a lot of attention in different engineering fields. In this research, a control algorithm was developed to incorporate formalize expert knowledge about the treatment of diabetes using fuzzy logic controller. This controller should be able to regulate the blood glucose (BG) level when the diabetic patient is subjected to a mixed meal disturbance or fluctuations in the measured glucose level due to error or noise in the measuring instrument. Fuzzy logic control is furthermore an advanced process control, which imitates the logic of human thought Figure 3. Simulation of the PID controller. Copyright 213 SciRes.
4 114 and much less rigid than calculations that computers generally perform. There are three steps for the process of a fuzzy logic algorithm: fuzzification, rules, and defuzzification. In this paper, it is assumed that there are two different inputs of fuzzy logic controller: the glucose concentration and the rate of change in glucose concentration, and one output of the dose of insulin. The process of transforming inputs and output characteristics including the interval of variation for each variable and the fuzzy sets associated with the type of membership function (MF) is called fuzzification method. By the definition of the input fuzzy set, as shown in Figure 4, and the output fuzzy set as shown in Figure 5, a total of 17 IF-THEN rules were classified, as presented in Table 1. These rules were of AND (min) type antecedent. The output of the fuzzy concept is obtained, using defuzzification. The defuzzification strategy is based on the centroid of the area under the curve. Therefore, using the defuzzification process, the output gets an exact number (insulin dosage). 4. Results of Controllers Tests 4.1. Single Mixed Meal Test No Disturbance Test In this type of test, we apply a single mixed meal and both controllers were examined to get the best response to this test. The following table, Table 2 shows the single mixed meal used in the simulation. Figure 6 shows the response of the plant to the single mixed meal with no controllers. In other words, there is no insulin infusion. Figure 7 shows the response of the plant to the single mixed meal when regulated by the PID method. Similarly, Figure 8 shows the response of the plant when controlled by the fuzzy logic controller. The measurement results obtained from this test are presented in Table Delay in Glucose Sensor Test Here, both controllers were tested against time delay in the glucose sensor (i.e. five minutes delay). The single mixed meal used in the simulation is as shown in the first test Table 2. Table 1. Rules of fuzzy logic controller. Rate Concentration Overlow Good High Higher Overhigh Overlow Zero Zero Norm Snorm Smore Low Zero Little Snorm More Most High Zero Norm More Smore Most Highest Zero Snorm Smore Most Most Table 2. Single mixed meal. Figure 4. MF of the inputs of fuzzy logic controller. Item Time, min Glucose, g FFA, g Protein, g Mixed meal Diabetes No Control Response Figure 5. MF of the output of fuzzy logic controller Figure 6. No control (no infused insulin) response of the plant to the single mixed meal. Copyright 213 SciRes.
5 Figure 7. PID controller response to single mixed meal Figure 8. FLC controller response to single mixed meal. Table 3. Measurement results of controllers to different tests of single mixed meal. Item No disturbance Sensor delay Sensor noise PID FLC PID FLC PID FLC No control Maximum glucose (mg/dl) Minimum glucose (mg/dl) Duration of Hyperglycemia (min) 541 Duration of Hypoglycemia (min) Total infused insulin (U) Infused insulin above basal (U) The response of the plant to the single mixed meal with time delay when controlled by the PID algorithm is shown in Figure 9. Similarly, the response of the plant when controlled by the FLC is shown in Figure 1. The measurement results obtained from this test are presented in Table Noise in Glucose Sensor Test In this type of test, we apply a single mixed meal as shown in the last section, with signal to noise ratio (SNR = 1 db) in the glucose sensor. The simulation responses for both controllers are shown in Figures 11 and 12. The measurement results obtained from this test are presented in Table Daily Life Test Here, we test how the controllers can deal with multi mixed meals and exercise, by supposing daily life of healthy people as shown in Table 4. Figure 13 shows the response of the plant to the daily life test when controlled by the PID approach. Similarly, Figure 14 shows the response of the plant when regulated using the FLC. Although, the mixed meal for lunch and the dinner Figure 9. PID controller response to 5 min time delay. has the same quantity, the blood glucose level has raised more after dinner than after lunch, thus infusing more insulin for both controllers, as shown in Figures 13 and 14. This result is due to the exercise that was done before the dinner time which caused the plasma FFA elevation, where increased availability of FFA at rest has an inhibi- Copyright 213 SciRes.
6 Figure 1. FLC controller response to 5 min time delay G: Plasma Glucose UI: Insulin Infusion I : Plasma Insulin Figure 11. PID controller response to noise in G. sensor Figure 12. FLC controller response to noise in G. sensor. tory effect on tissue glucose uptake, as shown in Figure 15. The measurement results obtained from daily life test are presented in Table 5. Table 4. Daily life of mixed meals and exercise. Item Time, min Glucose, g Protein, g FFA, g Breakfast Lunch Dinner Item Time, min Percentage of physical activity Exercise % Figure 13. PID controller response to daily life Figure 14. Fuzzy controller response to daily life. 5. Discussion and Conclusions In the delay test of a single mixed meal, when the glucose sensor has 5 minutes time delay, the PID controller can not keep the blood glucose (BG) level at the basal level, producing a big drop in the BG level below the basal line. This results from the wrong insulin doses, which has a short term effect on his/her life causing danger to the patient. In contrast, the overshoot of BG concentration in the FLC is a little more than what happened in the PID Copyright 213 SciRes.
7 117 F(t) (mu.mol/l) PVO2 (%) Percentage Physical Activity Plasma FFA Conc Time (min) Figure 15. (Top) Percentage physical activity, (Bottom) plasma FFA concentration. Table 5. Controllers measurement results of daily life test. Item PID FLC Maximum glucose (mg/dl) Minimum glucose (mg/dl) Duration of hyperglycemia (min) Duration of hypoglycemia (min) Total infused insulin (U) Infused insulin above basal (U) controller. Nevertheless, the FLC in the stage of steady state has a stable response with the basal level of the BG concentration, and the basal level of insulin infusion. Thus, the insulin infused by the FLC is less than the dosage infused by the PID controller as presented in Table 3. In comparison of the total insulin infusion in no disturbance test and sensor delay test, it is quite obvious that the 5 min time delay caused more insulin infusion in case of the PID controller, and made the most quantity of infused insulin above the basal level. In contrast, the FLC has infused almost similar quantities as shown in Table 3. In the noise test, when the glucose sensor has a 1 db SNR, this causes a big confusion in the response of the PID controller and this is shown clearly in the stage of steady state before and after the time of ingesting mixed meal. The response of the PID controller is not acceptable in the sense of control since the BG level has an oscillation causing a drop in BG level below the basal. In contrast, although the overshoot in the FLC is a little more than that what happen in the PID controller, the response of this controller in stage of steady state has kept the BG concentration almost at the basal level. The insulin infusion has a big fluctuation which will cause big extra effort on insulin pump. By comparing the total insulin infusion in no disturbance test and sensor noise test as presented in Table 3, it is very clear that noise has caused more insulin infusion in case of the PID controller compared to the FLC. Moreover, the PID has made the most infused quantity of insulin doses above the basal level. The PID controller in daily life test has a proper response where soon after the overshoot that happened due to the ingestion of mixed meal, the BG level returned back to the basal level. However, the overshoot in the FLC is little more than that what happened in the PID controller, where the effect of long time of high overshoot has a long term effect on the life of the patient. In the stage of steady state, both controllers have the basal level of BG concentration, and basal level of insulin infusion. However, the PID controller has big oscillation of insulin infusion in the period of exercise time, which will cause extra effort on insulin pump. Also it is clear from Table 5 that insulin infused by the FLC is less than by the PID controller. In conclusion, taking into account all previous tests with both controllers, there were no case of hyperglycemia (BG more than 27 mg/dl) or hypoglycemia (BG less than 6 mg/dl) as presented in Tables 3 and 5. However, resulting tables and figures have shown that the FLC is more reliable, safer and has less insulin consumption than the PID controller. Furthermore, real world cases should have a delay or/and noise in glucose sensor. Therefore, the FLC would be preferable and advisable when it comes to critical diabetes cases. REFERENCES [1] J. Chen, K. Cao, Y. Sun, Y. Xiao and X. Su, Continuous Drug Infusion for Diabetes Therapy: A Closed-Loop Control System Design, Eurasip Journal on Wireless Communications and Networking, Vol. 28, No. 44, 28, Article ID: [2] L. Kardar, A. Fallah, S. Gharibzadeh and F. Moztarzadeh, Application of Fuzzy Logic Controller for Intensive Insulin Therapy in Type 1 Diabetic Mellitus Patients by Subcutaneous Route, Biomedical Engineering, Amirkabir University of Technology, WSEAS Transactions on Systems and Control, Vol. 3, No. 9, 28, pp [3] A. Roy, Dynamic Modelling of Free Fatty Acid, Glucose, and Insulin during Rest and Exercise in Insulin Dependent Diabetes Mellitus Patients, University of Pittsburgh, Pittsburgh, 28. [4] E. D. Lehman and T. Deutsch, The Physiological Model of Glucose-Insulin Interaction in T1DM, Journal of Biomedical Engineering, Vol. 14, No. 3, 1992, pp doi:1.116/ (92)958-s [5] E. Berger, Modeling Diabetes to Achieve Closed-Loop Control of Glucose Levels: A Literature Review, Pennsylvania State University, 27. [6] E. Friis, Modeling and Simulation of Glucose-Insulin Metabolism, Technical University of Denmark, 27. Copyright 213 SciRes.
Insulin dosage based on risk index of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus with uncertain parameters and food intake
based on risk index of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus with uncertain parameters and food intake Remei Calm 1, Maira García-Jaramillo 1, Jorge Bondia 2, Josep Vehí 1 1
Calculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
Algorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW
CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW 1 P Srinivas 2 P.Durga Prasada Rao 1 Associate Professor, Department of EIE, VR Siddhartha Engineering College, Vijayawada, India Email:
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US
Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES Jo M. Kendrick, APN BC, CDE [email protected] Describe indications and contraindications for insulin pump use in hospitalized patients Differentiate
Self-tuning Insulin Adjustment Algorithm for Type I Diabetic Patients Based on Multi-Doses Regime.
International Simposium on Robotics and Automation 24 August 25-27, 24 Self-tuning Adjustment Algorithm for Type I Diabetic Patients Based on Multi-Doses Regime. D.U. Campos-Delgado Facultad de Ciencias
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control. Linda Macdonald, M.D. November 19, 2008
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control Linda Macdonald, M.D. November 19, 2008 Objectives Understand the relationship between insulin, carbohydrate intake, and blood
Title: Using Formal Methods to Improve Safety of Home-Use Medical Devices
Title: Using Formal Methods to Improve Safety of Home-Use Medical Devices Authors: Ayan Banerjee Impact Lab, Arizona State University [email protected] Yi Zhang Center for Devices and Radiological Health,
CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
Basal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction)
Basal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction) 4) activity and 5) other factors such as stress and
2. What Should Advocates Know About Diabetes? O
2. What Should Advocates Know About Diabetes? O ften a school district s failure to properly address the needs of a student with diabetes is due not to bad faith, but to ignorance or a lack of accurate
An Improved PID Switching Control Strategy for Type 1 Diabetes
An Improved PID Switching Control Strategy for Type 1 Diabetes Gianni Marchetti, Massimiliano Barolo, Lois Jovanovic, Howard Zisser, and Dale E. Seborg, Member, IEEE Department of Chemical Engineering
B. Braun Space GlucoseControl (SGC)
B. Braun Space GlucoseControl (SGC) Quick Reference Guide Valid for software I9305_C Automated Infusion Systems Starting a new insulin therapy SpaceControl cannot be switched on and off by itself. It is
Dietfree-Good News for Diabetics
Dietfree-Good News for Diabetics What is Dietfree? Dietfree is concentrated herbs developed Superdragon TCM UK Ltd and Chinese Medical Academy UK. It is made from a range of pure natural concentrated Chinese
Diabetes Health Care Plan
The Public Schools of Brookline School Health Services of Plan: Diabetes Health Care Plan To be completed by the student s health care team and parents/guardian. Plan will be kept with the school nurse
AN INTELLIGENT SUPPORT SYSTEM FOR DIABETIC PATIENTS
AN INTELLIGENT SUPPORT SYSTEM FOR DIABETIC PATIENTS Mark Hoogendoorn, Michel C. A. Klein, Nataliya M. Mogles VU University Amsterdam, Department of Artificial Intelligence, De Boelelaan 1081, Amsterdam,
Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.
Introduction Diabetes is a chronic disease that affects the body s ability to metabolize food. The body converts much of the food we eat into glucose, the body s main source of energy. Glucose is carried
Anomaly Detection in the Artificial Pancreas
INGAR Instituto de Desarrollo y Diseño Consejo Nacional de Investigaciones Científicas y Técnicas Universidad Tecnológica Nacional Anomaly Detection in the Artificial Pancreas Luis Ávila, Ernesto Martínez
Glucose-Insulin System based on Minimal Model: a Realistic Approach
2015 17th UKSIM-AMSS International Conference on Modelling and Simulation Glucose-Insulin System based on Minimal Model: a Realistic Approach Adriana Aguilera González, Holger Voos Interdisciplinary Centre
Type 1 Diabetes - Managing a Critical Ratio
Objectives Students will learn about how ratios and proportions are a key part of managing Type 1 Diabetes Students will learn about the regulation of blood glucose through insulin (hormone) binding with
Diabetes mellitus 1 عبد هللا الزعبي. pharmacology. Shatha Khalil Shahwan. 1 P a g e
Diabetes mellitus 1 pharmacology عبد هللا الزعبي 1 P a g e 4 Shatha Khalil Shahwan Diabetes mellitus The goals of the treatment of diabetes 1. Treating symptoms 2. Treating and Preventing acute complications
Abdulaziz Al-Subaie. Anfal Al-Shalwi
Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied
ALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
ALVIN INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan of Plan: School Year (must be current): This plan should be completed by the student s personal health care team and parents/guardian.
Type 1 Diabetes Management Based on Glucose Intake www.utmem.edu/endocrinology click Patients (Revised 7/13/2007)
Type 1 Diabetes Management Based on Glucose Intake www.utmem.edu/endocrinology click Patients (Revised 7/13/2007) The following is a system of insulin therapy, diet management, and blood glucose monitoring
Should We Count Fat and Protein in Bolus Insulin Dose Calculation: Does Carbohydrate Counting Work? Howard A. Wolpert, MD
Should We Count Fat and Protein in Bolus Insulin Dose Calculation: Does Carbohydrate Counting Work? Howard A. Wolpert, MD Carbohydrate to Insulin Ratio, circa 1935 Standard Insulin Replacement Regimen
Diabetes Management and Treatment Plan for School (For the insulin pump student)
Lafayette School Corporation Health Services Diabetes Management and Treatment Plan for School (For the insulin pump student) Effective Dates: This plan should be complete by the student s personal health
Continuous Subcutaneous Insulin Infusion (CSII)
IMPORTANCE OF FOCUS CSII (Insulin pumps) have been used for more than 35 years. In the U.S. in 2005, the level of insulin pump penetration was estimated at 20 to 30% in patients with type 1 diabetes mellitus
Insulin therapy in various type 1 diabetes patients workshop
Insulin therapy in various type 1 diabetes patients workshop Bruce H.R. Wolffenbuttel, MD PhD Dept of Endocrinology, UMC Groningen website: www.umcg.net & www.gmed.nl Twitter: @bhrw Case no. 1 Male of
4/7/2015 CONFLICT OF INTEREST DISCLOSURE OBJECTIVES. Conflicts of Interest None Heather Rush. Heather M. Rush, APRN, CDE Louisville, KY
Heather M. Rush, APRN, CDE Louisville, KY CONFLICT OF INTEREST DISCLOSURE Conflicts of Interest None Heather Rush A conflict of interest exists when an individual is in a position to profit directly or
Taking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT
Taking Insulin Pumps to School Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT Insulin Pumps Today A micro-computer, about the size of a pager Programmed to deliver both a preset amount
OFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN
PART I OFFICE OF CATHOLIC SCHOOLS DIOCESE OF ARLINGTON DIABETES MEDICAL MANAGEMENT PLAN Page 1 of 5 TO BE COMPLETED BY PARENT OR GUARDIAN Student School Date of Birth Date of Diagnosis Grade/ Teacher Physical
GLUCOSE HOMEOSTASIS-II: An Overview
GLUCOSE HOMEOSTASIS-II: An Overview University of Papua New Guinea School of Medicine & Health Sciences, Division of Basic Medical Sciences Discipline of Biochemistry & Molecular Biology, M Med Part I
Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro
PRESS RELEASE Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro BioChaperone Lispro is significantly faster than Humalog in type I diabetic patients;
ARTICLE IN PRESS Biomedical Signal Processing and Control xxx (2012) xxx xxx
Biomedical Signal Processing and Control xxx (2012) xxx xxx Contents lists available at SciVerse ScienceDirect Biomedical Signal Processing and Control journa l h omepage: www.elsevier.com/locate/bspc
Insulin Pump Therapy. Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology
Insulin Pump Therapy Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology Disclosures Member of Clinical Advisory Panel for Tandem Work on a variety of clinical trials funded
The Basics of Insulin Pump Therapy
The Basics of Insulin Pump Therapy Table of Contents The Basics of Insulin Pump Therapy Introduction Welcome... 3 Chapter 1 Balancing Glucose and Insulin............................. 10 Section 1: Glucose,
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
Diabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
Alternative method for delivering insulin using continuous subcutaneous insulin infusion (CSII) open loop system
ISHP Spring CE Conference April 12, 2015 St. Luke s Medical Center Randi Lynn Griffiths, PharmD Clinical outpatient pharmacist Boise VA Medical Center Boise, Idaho Alternative method for delivering insulin
INSULIN PRODUCTS. Jack DeRuiter
INSULIN PRODUCTS Jack DeRuiter The number and types of insulin preparations available in the United States is constantly changing, thus students should refer to recent drug resources for a current list
Implementation of Fuzzy and PID Controller to Water Level System using LabView
Implementation of Fuzzy and PID Controller to Water Level System using LabView Laith Abed Sabri, Ph.D University of Baghdad AL-Khwarizmi college of Engineering Hussein Ahmed AL-Mshat University of Baghdad
Advisors: Masahiko Saito, Mathematics and Statistics Scott Campbell, Chemical & Biomedical Engineering. Problem Suggested By: Scott Campbell
Undergraduate Journal of Mathematical Modeling: One + Two Volume 3 2011 Spring Issue 2 Article 12 Blood Glucose Levels Carlos Estela University of South Florida Advisors: Masahiko Saito, Mathematics and
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus Louis Haenel, IV, DO, FACOI, FACE Endocrinology Roper Hospital Charleston, SC Dr. Louis Haenel IV has disclosed
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Haidar A, Legault L, Matteau-Pelletier L, et
Pump Therapy Indications:
Insulin Pumping Getting Started March 7, 2008 Clinical Pearls To understand the rational behind pump therapy To explore patient preferences for and against insulin pump therapy Realistic expectations for
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy In addition to using the blood sugar logs to adjust your insulin doses every week, you should also use your continuous glucose
School Year 20 / 20. Diabetes Health Care Plan for Southgate Schools
School Year 20 / 20 Diabetes Health Care Plan for Southgate Schools Diabetes Medical Management Plan, Initialized Healthcare Plan and Physician Orders Part A: Contact Information must be completed by the
DIABETIC EDUCATION MODULE ONE GENERAL OVERVIEW OF TREATMENT AND SAFETY
DIABETIC EDUCATION MODULE ONE GENERAL OVERVIEW OF TREATMENT AND SAFETY First Edition September 17, 1997 Kevin King R.N., B.S., C.C.R.N. Gregg Kunder R.N., B.S.N., C.C.T.C. 77-120 CHS UCLA Medical Center
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
MANAGING DIET ON AN INSULIN PUMP.
Patient Information MANAGING DIET ON AN INSULIN PUMP. Dietetic Department Therapy Services Shrewsbury and Telford NHS Trust 1 Food Bolusing on a pump (ADJUSTING YOUR INSULIN WITH YOUR DIET) Hopefully you
Health Professional s. Guide to INSULIN PUMP THERAPY
Health Professional s Guide to INSULIN PUMP THERAPY Table of Contents Introduction Presenting Insulin Pump Therapy to Your Patients When Your Patient Chooses the Pump Estimates for Starting Insulin Pump
FHUSD Diabetic Management Plan
This plan should be completed by the student s personnel Physician or Licensed Healthcare Provider and parent/guardian. It should be reviewed with relevant school staff and copies should be kept in a place
tips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:
tips Top International Publications Selection Insulin Pump Users Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated Patients with TD Population Study of Pediatric
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
Diabetes Self Management Training Insulin Pump Follow Up
701 East Marshall Street, West Chester, PA 19380 www.chestercountyhospital.org 610.431.5000 Diabetes Self Management Training Insulin Pump Follow Up Patient Name: Visit Date: Time: To prepare for your
Medical Policy Insulin Pumps
Medical Policy Insulin Pumps Document Number: 027 Authorization required Insulin Pumps & supplies Notification within 24 hours of service or next business day No Prior Authorization Not covered Pulsatile
Reducing the risk of patient harm: A focus on insulin
Reducing the risk of patient harm: A focus on insulin New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 1 Disclosure Matt Fricker, Matt Grissinger,
Automatic Blood Glucose Control in Diabetes
Automatic Blood Glucose Control in Diabetes Marit Owren Master of Science in Engineering Cybernetics Submission date: June 29 Supervisor: Bjarne Anton Foss, ITK Norwegian University of Science and Technology
The What, Why, Who & How of Insulin Pumps. Bridget Lydon May 2014
The What, Why, Who & How of Insulin Pumps Bridget Lydon May 2014 Topics WHAT is an insulin pump HOW a pump works WHY use a pump WHO should use a pump Pharmac criteria for funded pumps All began back in
ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes
DIABETES MELLITUS DEFINITION It is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. Resulting from absolute lack of insulin. Abnormal metabolism of
Insulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE [email protected]
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE [email protected] Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
Is what you know about INSULIN PUMP THERAPY. This educational resource is provided by Medtronic MiniMed, Inc.
Is what you know about INSULIN PUMP THERAPY MYTH or? This educational resource is provided by Medtronic MiniMed, Inc. You have to know a lot about technology to learn to use a pump Interacting with your
Medical Coverage Policy Glucose Monitoring Systems sad
Medical Coverage Policy Glucose Monitoring Systems sad EFFECTIVE DATE: 03 03 2009 POLICY LAST UPDATED: 01 17 2012 OVERVIEW This policy addresses several methods of monitoring blood glucose: the glucometer,
Carbohydrate Counting and Insulin. Diabetes Care Group www.diabetescaregrp.com
Carbohydrate Counting and Insulin Diabetes Care Group www.diabetescaregrp.com 1 Objectives State carbohydrate grams in commonly eaten foods Determine total carbohydrate grams using a nutrition label or
Telephone: Home Work Cell E-mail Address Father/Guardian: Address:
SAMPLE Diabetes Medical Management Plan/Individualized Healthcare Plan Part A: Contact Information must be completed by the parent/guardian. Part B: Diabetes Medical Management Plan (DMMP) must be completed
Proceeding of 5th International Mechanical Engineering Forum 2012 June 20th 2012 June 22nd 2012, Prague, Czech Republic
Modeling of the Two Dimensional Inverted Pendulum in MATLAB/Simulink M. Arda, H. Kuşçu Department of Mechanical Engineering, Faculty of Engineering and Architecture, Trakya University, Edirne, Turkey.
Endocrine System: Practice Questions #1
Endocrine System: Practice Questions #1 1. Removing part of gland D would most likely result in A. a decrease in the secretions of other glands B. a decrease in the blood calcium level C. an increase in
INSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES. Living your life as normal as possible
WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES DEDBT01954 Lilly Deutschland GmbH Werner-Reimers-Straße 2-4 61352 Bad Homburg Living your life as normal as possible www.lilly-pharma.de www.lilly-diabetes.de
User guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
Insulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
Universita degli Studi di Padova Facolta di Ingegneria
Universita degli Studi di Padova Facolta di Ingegneria Finito di scrivere il giorno September 5, 01 utilizzando L A TEX ε UNIVERSITÀ DEGLI STUDI DI PADOVA FACOLTÀ DI INGEGNERIA Dipartimento di Ingegneria
How to design an insulin pump
How to design an insulin pump Learn about the purpose of an insulin pump, its overall workings, and the requirements needed for its design as well as implementation. By Asha Ganesan Applications Engineer
Carbohydrate Ratio Correction Target Correction Factor
Information Needed to Get Started How many grams of carbs the child is eating Blood glucose (BG) taken before eating Important numbers from primary caregiver: Carbohydrate Ratio Correction Target Correction
Section 504 Plan (pg 1 of 8)
Section 504 Plan (pg 1 of 8) of Birth School Today s Section 504 Plan for: Disability: Diabetes School Year: Grade: Homeroom Teacher: Bus Number: Background Objectives The student has type diabetes. Diabetes
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
Diabetes and Technology. Disclosures Certified Insulin Pump Trainer for: Animas Medtronic Diabetes Omnipod. Rebecca Ray, MSN, APRN, FNP-C
Diabetes and Technology Rebecca Ray, MSN, APRN, FNP-C Insulin Pump Therapy and Continuous Glucose Monitoring In Patients with Type 2 Diabetes Page 1 Disclosures Certified Insulin Pump Trainer for: Animas
Design of an Insulin Pump. Purpose of an Insulin Pump:
Design of an Insulin Pump Purpose of an Insulin Pump: Insulin is a hormone central to regulating carbohydrate and fat metabolism in the body. It is secreted regularly within the body and aids in converting
Intensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy Advantages of insulin pump therapy There are many advantages to using an insulin pump. Anyone can do it with the right training and support.
The Background for the Diabetes Detection Model
The Background for the Diabetes Detection Model James K. Peterson Department of Biological Sciences and Department of Mathematical Sciences Clemson University November 23, 2014 Outline The Background for
Your Insulin Adjustment Workbook Yes, You Can Do It!
S T AY I N G O N T A R G E T TARGET THERAPY Staying on Target TM Your Insulin Adjustment Workbook Yes, You Can Do It! YES, YOU CAN DO IT! Your How-To Guide for Adjusting Basal and Bolus Insulin This workbook
1.00 REGULATORY AUTHORITY
ARKANSAS DEPARTMENT OF EDUCATION AND ARKANSAS STATE BOARD OF NURSING RULES GOVERNING THE ADMINISTRATION OF INSULIN AND GLUCAGON TO ARKANSAS PUBLIC SCHOOL STUDENTS SUFFERING FROM DIAGNOSED WITH DIABETES
BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS
CHAPTER 6: BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS WHAT IS BOLUS INSULIN? Bolus insulin dosages refer to the quick bursts of insulin given to cover the carbohydrates in meals or snacks
Optimized Fuzzy Control by Particle Swarm Optimization Technique for Control of CSTR
International Journal of Computer, Electrical, Automation, Control and Information Engineering Vol:5, No:, 20 Optimized Fuzzy Control by Particle Swarm Optimization Technique for Control of CSTR Saeed
X-Plain Hypoglycemia Reference Summary
X-Plain Hypoglycemia Reference Summary Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized
Diabetes Education Information for Teachers and School staff
Diabetes Education Information for Teachers and School staff The information below is intended to educate school staff on the basics of diabetes care. If you have a student in your classroom or you will
